The following trials provide information to treat various types of gastrointestinal diseases, both for ongoing and completed clinical trials. For more information on this therapy area please click here.
- collapse To Assess the Efficacy of Esomeprazole 40 mg Once Daily in Subjects Who Still Had Heartburn After Receiving Rabeprazole
- collapse A Multicenter, Randomized, Open-label Phase IV Study Exploring Symptom Control Rate in Co-diagnosed NERD and Chronic Gastritis Patients Treated With 8 Weeks Esomeprazole Treatment Regimen and 2 Weeks Esomeprazole Treatment Regimen
- collapse An open-label, randomized, 4-treatment, 3-period, crossover interaction study, evaluating the effect of esomeprazole 40 mg, omeprazole 80 mg or lansoprazole 60 mg on the pharmacodynamics and the pharmacokinetics of clopidogrel in healthy volunteers
- collapse China Survey of Peptic Ulcer Bleeding (PUB)
- collapse A cross-sectional study on the prevalence and extraesophageal symptoms of GERD in patients with upper GI symptoms, visiting the outpatient departments of peripheral hospitals in Greece.
- collapse Prevalence of GERD in Patients with upperGITsymptoms in Thailand
- collapse A multicentre, double-blind, randomised, parallel-group, Phase II study to assess efficacy and safety of D9421-C 9 mg, and 15 mg versus in patients with active Crohn's Disease in Japan
- collapse A double-blind, randomized, placebo-controlled, two-centre, phase IIa pharmacodynamic cross-over study to assess the effect of AZD2516 on the total number of reflux episodes in healthy male volunteers
- collapse A National, Multicentre, Open-label, Non-comparative, Non-interventional Survey Examining the Frequency and Severity of Acid Related Symptoms While Taking Nexium
